106 days ago
Roquefort Therapeutics (ROQ) stated in May that the sale of Oncogeni Ltd would see a binding SPA signed in June with completion for up to $12 million “shortly thereafter”. As I flagged up to the FCA yesterday there has been no RNS since June to confirm this or to flag up a problem. So, what does Companies House say?